Nuclein Revenue and Competitors
Estimated Revenue & Valuation
- Nuclein's estimated annual revenue is currently $10.5M per year.
- Nuclein's estimated revenue per employee is $155,000
Employee Data
- Nuclein has 68 Employees.
- Nuclein grew their employee count by 33% last year.
Nuclein's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientist | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Director Software Engineering | Reveal Email/Phone |
5 | Associate Director, Quality | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | Regional Sales Manager | Reveal Email/Phone |
8 | Senior Software Engineering Manager | Reveal Email/Phone |
9 | Assay Development Manager | Reveal Email/Phone |
10 | Product Development Manager | Reveal Email/Phone |
Nuclein Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Nuclein?
Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample. The company is headquartered in Austin, Texas.
keywords:N/AN/A
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.9M | 68 | -44% | $33.2M |
#2 | $8.9M | 68 | -14% | N/A |
#3 | $17.1M | 68 | 0% | N/A |
#4 | $16.5M | 68 | -4% | N/A |
#5 | $15.3M | 68 | 8% | N/A |